Targeting SLC1A5 and SLC3A2/SLC7A5 as a potential strategy to strengthen anti-tumor immunity in the tumor microenvironment

M Nachef, AK Ali, SM Almutairi, SH Lee - Frontiers in immunology, 2021 - frontiersin.org
Cancer cells are metabolically vigorous and are superior in the uptake of nutrients and in the
release of the tumor microenvironment (TME)-specific metabolites. They create an acidic …

Plasmodium Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution

X Su, KD Lane, L Xia, JM Sá… - Clinical microbiology …, 2019 - Am Soc Microbiol
Protozoan Plasmodium parasites are the causative agents of malaria, a deadly disease that
continues to afflict hundreds of millions of people every year. Infections with malaria …

Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc

Y Lee, P Wiriyasermkul, C Jin, L Quan… - Nature structural & …, 2019 - nature.com
The L-type amino acid transporter 1 (LAT1 or SLC7A5) transports large neutral amino acids
across the membrane and is crucial for brain drug delivery and tumor growth. LAT1 forms a …

The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1

CG Hansen, YLD Ng, WLM Lam, SW Plouffe, KL Guan - Cell research, 2015 - nature.com
YAP and TAZ are transcriptional co-activators and function as the major effectors of the
Hippo tumor suppressor pathway, which controls cell growth, tissue homeostasis, and organ …

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

P Xia, A Dubrovska - Frontiers in Oncology, 2023 - frontiersin.org
The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2).
CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+ LAT1 (SLC7A7), y+ …

Attacking the supply wagons to starve cancer cells to death

EM Selwan, BT Finicle, SM Kim, AL Edinger - FEBS letters, 2016 - Wiley Online Library
The constitutive anabolism of cancer cells not only supports proliferation but also addicts
tumor cells to a steady influx of exogenous nutrients. Limiting access to metabolic substrates …

Heteromeric solute carriers: function, structure, pathology and pharmacology

SJ Fairweather, N Shah, S Brӧer - Protein Reviews: Volume 21, 2021 - Springer
Solute carriers form one of three major superfamilies of membrane transporters in humans,
and include uniporters, exchangers and symporters. Following several decades of …

Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma

Y Yang, A Bolomsky, T Oellerich, P Chen… - Nature …, 2022 - nature.com
Oncogenic RAS mutations are common in multiple myeloma (MM), an incurable malignancy
of plasma cells. However, the mechanisms of pathogenic RAS signaling in this disease …

SLC3A2 N-glycosylation and Golgi remodeling regulate SLC7A amino acid exchangers and stress mitigation

C Zhang, M Shafaq-Zadah, J Pawling… - Journal of Biological …, 2023 - ASBMB
Proteostasis requires oxidative metabolism (ATP) and mitigation of the associated damage
by glutathione, in an increasingly dysfunctional relationship with aging. SLC3A2 (4F2hc …

The E3 ubiquitin ligase MARCH1 regulates antimalaria immunity through interferon signaling and T cell activation

J Wu, L Xia, X Yao, X Yu, KC Tumas… - Proceedings of the …, 2020 - National Acad Sciences
Malaria infection induces complex and diverse immune responses. To elucidate the
mechanisms underlying host–parasite interaction, we performed a genetic screen during …